June 20, 2014
Endo Pharmaceuticals Inc. and Impax Laboratories Inc. were hit with a proposed antitrust class action in Illinois federal court Thursday, alleging Endo paid the generics manufacturer over $112 million in exchange for Impax's delaying a generic version of Endo's patented Opana ER painkiller.